Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Behind-The-Counter Sale Is No Deterrent To Brand Loyalty – Survey

This article was originally published in The Tan Sheet

Executive Summary

Behind-the-counter status does not diminish customers' loyalty to brand name nonprescription drugs, according to results of a nationwide survey

You may also be interested in...

In-Store Clinics Could Boost OTCs, But Pose Possible Appearance Of Conflict

The growth of in-store health care clinics could lead to consumers more often opting for OTC products over receiving prescriptions, but also creates the possibility for the appearance of conflicts of interest involving the host retail sites and the clinic operators, health care association executives say

Behind-The-Counter Sale Works Without Regulation – Former FDA Counsel

FDA's interest in establishing an official third class of drugs, as well as the OTC industry's concern about the idea, could be diminished because the agency already allows a path to behind-the-counter sales in new drug and switch applications, according to a former FDA chief counsel

In Rare Cannabinoids, BioMedican Sees Alphabet Of Potential Dietary And Drug Ingredients

BioMedican is ready to produce CBG, cannabigerol, and THC-V, tetrahydrocannabivarin, through biosynthesis and plans by the end of the year to start making CBN, cannabinol, and THC-A, tetrahydrocannabinolic-acid.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts